Your browser doesn't support javascript.
loading
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Menghrajani, Kamal; Gomez-Arteaga, Alexandra; Madero-Marroquin, Rafael; Zhang, Mei-Jie; Bo-Subait, Khalid; Sanchez, Jonathan; Wang, Hai-Lin; Aljurf, Mahmoud; Assal, Amer; Bacher, Vera Ulrike; Badawy, Sherif M; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Christopher; Byrne, Michael; Castillo, Paul; Cerny, Jan; Chhabra, Saurabh; Ciurea, Stefan Octavian; DeFilipp, Zachariah; Farhadfar, Nosha; Gadalla, Shahinaz; Gale, Robert Peter; Ganguly, Siddhartha; Gowda, Lohith; Grunwald, Michael R; Hashmi, Shahrukh; Hildebrandt, Gerhard; Kanakry, Christopher G; Kansagra, Ankit; Khimani, Farhad; Krem, Maxwell; Lazarus, Hillard; Liu, Hongtao; Martino, Rodrigo; Michelis, Fotios V; Nathan, Sunita; Nishihori, Taiga; Olsson, Richard; Reshef, Ran; Rizzieri, David; Rowe, Jacob M; Savani, Bipin N; Seo, Sachiko; Sharma, Akshay; Solh, Melhem; Ustun, Celalettin; Verdonck, Leo F; Hourigan, Christopher; Sandmaier, Brenda.
Afiliación
  • Menghrajani K; Leukemia Service and.
  • Gomez-Arteaga A; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Madero-Marroquin R; Department of Medicine, Icahn School of Medicine, Mount Sinai St Luke's and Mount Sinai West, New York, NY.
  • Zhang MJ; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine and.
  • Bo-Subait K; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
  • Sanchez J; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine and.
  • Wang HL; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine and.
  • Aljurf M; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine and.
  • Assal A; Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia.
  • Bacher VU; Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY.
  • Badawy SM; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Bejanyan N; Division of Hematology, Oncology and Stem Cell Transplant, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
  • Bhatt VR; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Bredeson C; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Byrne M; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE.
  • Castillo P; The Ottawa Hospital Blood and Marrow Transplant Program, Ottawa ON, Canada.
  • Cerny J; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Chhabra S; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN.
  • Ciurea SO; Division of Hematology & Oncology, Department of Pediatrics in the College of Medicine, UF Health Shands Children's Hospital, Gainesville, FL.
  • DeFilipp Z; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA.
  • Farhadfar N; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine and.
  • Gadalla S; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Gale RP; Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ganguly S; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA.
  • Gowda L; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL.
  • Grunwald MR; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI) Clinical Genetics Branch, National Institutes of Health (NIH), Rockville, MD.
  • Hashmi S; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Hildebrandt G; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS.
  • Kanakry CG; Section of Hematology, Department of Medicine, Yale University School of Medicine, Yale Comprehensive Cancer Center, Yale New Haven Hospital, New Haven, CT.
  • Kansagra A; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Khimani F; Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Krem M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Lazarus H; Markey Cancer Center, University of Kentucky, Lexington, KY.
  • Liu H; Experimental Transplantation and Immunology Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD.
  • Martino R; UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX.
  • Michelis FV; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Nathan S; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY.
  • Nishihori T; Department of Medicine, University Hospitals Case Medical Center and Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH.
  • Olsson R; Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL.
  • Reshef R; Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Rizzieri D; Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Rowe JM; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL.
  • Savani BN; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE.
  • Seo S; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Sharma A; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Solh M; Blood and Marrow Transplantation Program and.
  • Ustun C; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
  • Verdonck LF; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC.
  • Hourigan C; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Sandmaier B; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Blood Adv ; 6(3): 828-847, 2022 01 08.
Article en En | MEDLINE | ID: mdl-34551064
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos